National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 81924-81925 [2024-23361]
Download as PDF
<![CDATA[
khammond on DSKJM1Z7X2PROD with NOTICES
81924
Federal Register / Vol. 89, No. 196 / Wednesday, October 9, 2024 / Notices
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Mariam Zaka, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1009J,
Bethesda, MD 20892, (301) 435–1042,
zakam2@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
HEAL Initiative Advanced Postdoctoral-toIndependent Career Transition Award in
PAIN and SUD Research to Promote Diversity
Review.
Date: November 6, 2024.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Katherine M Malinda,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4140,
MSC 7814, Bethesda, MD 20892, (301) 435–
0912, malindakm@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business Panel: Respiratory Sciences.
Date: November 6–7, 2024.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge, Drive
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Michael L Bloom, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6187,
MSC 7804, Bethesda, MD 20892, 301–451–
0132, bloomm2@mail.nih.gov.
Name of Committee: Infectious Diseases
and Immunology B Integrated Review Group;
Bacterial-Host Interactions Study Section.
Date: November 6–7, 2024.
Time: 9:30 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Uma Basavanna, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 827–1398, uma.basavanna@
nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Aging, Neurodegeneration, and
Neurotoxicology.
Date: November 6–7, 2024.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: M. Catherine Bennett,
Ph.D., Scientific Review Officer, Center for
VerDate Sep<11>2014
17:05 Oct 08, 2024
Jkt 265001
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5182,
MSC 7846, Bethesda, MD 20892, 301–435–
1766, bennettc3@csr.nih.gov.
Name of Committee: Population Sciences
and Epidemiology Integrated Review Group;
Analytics and Statistics for Population
Research Panel B Study Section.
Date: November 6–7, 2024.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Victoriya Volkova, DVM,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20817, (301) 594–7781, volkovav2@
csr.nih.gov.
Dated: October 3, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2024–23354 Filed 10–8–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; Interdisciplinary Team
Science to Uncover the Mechanisms of Pain
Relief by Medical Devices (RM1 Clinical
Trial Optional).
Date: November 7, 2024.
Time: 10:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications and/or proposals.
Name of Committee: National Institutes of
Health, Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852.
Meeting Format: Virtual Meeting.
Contact Person: Nilkantha Sen, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Activities,
NINDS/NIH/DHHS, NSC, 6001 Executive
Blvd., Rockville, MD 20852, 301–496–9223,
nilkantha.sen@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS).
Dated: October 3, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2024–23355 Filed 10–8–24; 8:45 am]
BILLING CODE 4140–01–P
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meetings
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
National Institutes of Health
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; Biologics Contract Review
Meeting.
Date: November 4, 2024.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate contract
proposals.
Address: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852.
Meeting Format: Virtual Meeting.
Contact Person: Mirela Milescu, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Activities,
NINDS/NIH/DHHS, NSC, 6001 Executive
Blvd., Rockville, MD 20852, 301–496–5720,
mirela.milescu@nih.gov.
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Centers for Research in
Emerging Infectious Diseases (CREID)
Network (U01 Clinical Trial Not Allowed).
Date: November 6–8, 2024.
Time: 9:00 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3E70A,
E:\FR\FM\09OCN1.SGM
09OCN1
Federal Register / Vol. 89, No. 196 / Wednesday, October 9, 2024 / Notices
Rockville, MD 20892 (Video Assisted
Meeting).
Contact Person: Annie Walker-Abbey,
Ph.D., Scientific Review Officer, Scientific
Review Program, Division of Extramural
Activities, National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3E70A,
Rockville, MD 20892, 240–627–3390,
aabbey@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: October 3, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2024–23321 Filed 10–8–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: October 3, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
National Institutes of Health
[FR Doc. 2024–23361 Filed 10–8–24; 8:45 am]
Notice is hereby given of a change in
the meeting of the Pathophysiology of
Obesity and Metabolic Disease Study
Section, October 29, 2024, 10:00 a.m. to
October 30, 2024, 06:30 p.m., National
Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892
which was published in the Federal
Register on October 01, 2024, 89 FR
79935.
This meeting is being amended to
change the contact person from Dr.
Heather Marie Brockway to Elaine
Sierra-Rivera. The meeting is closed to
the public.
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Alcohol Abuse
and Alcoholism; Notice of Closed
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
khammond on DSKJM1Z7X2PROD with NOTICES
(Catalogue of Federal Domestic Assistance
Program Nos. 93.273, Alcohol Research
Programs, National Institutes of Health, HHS)
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Special
Emphasis Panel, Preclinical Medications
Screening in Dependence Models of Alcohol
Use Disorders.
Date: November 1, 2024.
Time: 2:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institute of Health,
National Institute on Alcohol Abuse and
Alcoholism, 6700B Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Ranga V. Srinivas, Ph.D.,
Chief, Extramural Project Review Branch,
National Institute on Alcohol Abuse and
Alcoholism, 6700 B Rockledge Drive, Room
2114, National Institutes of Health, Bethesda,
MD 20892, (301) 451–2067, srinivar@
mail.nih.gov.
VerDate Sep<11>2014
17:05 Oct 08, 2024
Jkt 265001
Center for Scientific Review; Amended
Notice of Meeting
Dated: October 3, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2024–23350 Filed 10–8–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
[Docket ID: FEMA–2024–0027]
MSA Delineations Used in FEMA’s
Grant Programs
Federal Emergency
Management Agency, Department of
Homeland Security.
ACTION: Notice and request for comment.
AGENCY:
Consistent with the
Metropolitan Areas Protection and
Standardization Act of 2021, the Federal
Emergency Management Agency
(FEMA) requests public comment on the
adoption of updated Metropolitan
Statistical Area delineations for use in
certain of FEMA’s grant programs.
DATES: Comments must be received no
later than December 9, 2024.
ADDRESSES: You may submit comments,
identified by Docket ID: FEMA–2024–
SUMMARY:
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
81925
0027, via the Federal eRulemaking
Portal: https://www.regulations.gov.
Follow the instructions for submitting
comments.
FOR FURTHER INFORMATION CONTACT:
Edgardo Santos, Risk Methodology
Branch Chief, Federal Emergency
Management Agency, FEMA-MSAProcess@fema.dhs.gov, (800) 368–6498.
SUPPLEMENTARY INFORMATION:
I. Public Participation
Interested persons are invited to
participate in this notice by submitting
comments and related materials. We
will consider all comments and
materials received during the comment
period.
If you submit a comment, include the
Docket ID, indicate the specific section
of this document to which each
comment applies, and give the reason
for each comment. All submissions may
be posted, without change, to the
Federal e-Rulemaking Portal at https://
www.regulations.gov, and will include
any personal information you provide.
Therefore, submitting this information
makes it public. For more about privacy
and the docket, visit https://
www.regulations.gov/privacy-notice.
For access to the docket to read
background documents or comments
received, go to the Federal eRulemaking Portal at https://
www.regulations.gov.
II. Background
A. FEMA Grant Programs and Core
Based Statistical Areas
FEMA has the statutory authority to
deliver numerous disaster and nondisaster financial assistance programs in
support of its mission, and that of the
U.S. Department of Homeland Security
(DHS), largely through grants and
cooperative agreements. Preparedness
grants 1 support our citizens and first
responders to ensure we work together
as a nation to build, sustain and
improve our capability to prepare for,
protect against, respond to, recover from
and mitigate terrorism and other highconsequence disasters and emergencies.
When determining eligibility for the
Urban Area Security Initiative, the
Tribal Homeland Security Grant
Program, the Nonprofit Security Grant
Program, the Port Security Grant
Program, the Transit Security Grant
1 For the purposes of this notice, the relevant
grants programs are the Urban Area Security
Initiative, the Tribal Homeland Security Grant
Program, the Nonprofit Security Grant Program, the
Port Security Grant Program, the Transit Security
Grant Program, and the Regional Catastrophic
Preparedness Grant Program. FEMA’s authority to
administer these programs is provided below.
E:\FR\FM\09OCN1.SGM
09OCN1
]]>Agencies
[Federal Register Volume 89, Number 196 (Wednesday, October 9, 2024)]
[Notices]
[Pages 81924-81925]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-23361]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; Centers for Research in Emerging
Infectious Diseases (CREID) Network (U01 Clinical Trial Not
Allowed).
Date: November 6-8, 2024.
Time: 9:00 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 3E70A,
[[Page 81925]]
Rockville, MD 20892 (Video Assisted Meeting).
Contact Person: Annie Walker-Abbey, Ph.D., Scientific Review
Officer, Scientific Review Program, Division of Extramural
Activities, National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 3E70A,
Rockville, MD 20892, 240-627-3390, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: October 3, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-23361 Filed 10-8-24; 8:45 am]
BILLING CODE 4140-01-P
